Recomienda este artículo a tus amigos:
The Impact of Off-Label, Compassionate, and Unlicensed Use on Health Care Laws in Preselected Countries Vanessa Plate
The Impact of Off-Label, Compassionate, and Unlicensed Use on Health Care Laws in Preselected Countries
Vanessa Plate
In times of situational therapeutic impasse, health care professionals (HCPs) are under pressure to conduct off-label, unlicensed and compassionate drug use -- generally summarized under the term non-licensed drug use (NDU). Liability, contractual and penal risks pose a problem when treating a patient in a non-licensed way. There is a knowledge gap about institutional and governmental methods to resolve these problems. Different countries have developed strategies to manage NDU. Vanessa Platé gives a comprehensive overview of practices Canada, the U. S., the U. K., Japan, France, Germany, Switzerland, Austria, and the transnational E. U. A must-read for everyone interested in the discussion on how to administer the best treatment, especially regarding early access to yet unapproved treatments.
174 pages, fig: 11, b&w, table: 32, b&w
| Medios de comunicación | Libros Paperback Book (Libro con tapa blanda y lomo encolado) |
| Publicado | 1 de julio de 2010 |
| Fecha de lanzamiento original | 2021 |
| ISBN13 | 9783838201351 |
| Editores | ibidem-Verlag, Jessica Haunschild u Chri |
| Páginas | 174 |
| Dimensiones | 148 × 210 × 15 mm · 217 g |
| Lengua | Inglés |